NCT06339996 Male Supplements for Sperm Quality and Aging
| NCT ID | NCT06339996 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kaohsiung Veterans General Hospital. |
| Condition | Unrecognized Condition |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-03-26 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-03-26 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the effects of a new supplement on sperm quality in men with poor sperm quality. Fifty patients will receive the supplement for three months, followed by semen analysis and assessment of sperm aging and mitochondrial function. Changes in sexual function and aging symptoms will also be evaluated.
Eligibility Criteria
Inclusion Criteria: * Not meet the criteria of the 6th edition of the WHO manual for human semen analysis * BMI:18-30 kg/m2 Exclusion Criteria: * Azoospermia * Varicocele * Chromosome anomaly * Malignancy * Using hormone therapy or supplements in recent 3 months
Contact & Investigator
Kuan-Hao Tsui
STUDY DIRECTOR
Kaohsiung Veterans General Hospital.
Frequently Asked Questions
Who can join the NCT06339996 clinical trial?
This trial is open to male participants only, aged 30 Years or older, up to 50 Years, studying Unrecognized Condition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06339996 currently recruiting?
Yes, NCT06339996 is actively recruiting participants. Contact the research team at litelin1982@gmail.com for enrollment information.
Where is the NCT06339996 trial being conducted?
This trial is being conducted at Kaohsiung City, Taiwan.
Who is sponsoring the NCT06339996 clinical trial?
NCT06339996 is sponsored by Kaohsiung Veterans General Hospital.. The principal investigator is Kuan-Hao Tsui at Kaohsiung Veterans General Hospital.. The trial plans to enroll 50 participants.